全文获取类型
收费全文 | 24398篇 |
免费 | 2892篇 |
国内免费 | 446篇 |
专业分类
耳鼻咽喉 | 197篇 |
儿科学 | 288篇 |
妇产科学 | 372篇 |
基础医学 | 957篇 |
口腔科学 | 276篇 |
临床医学 | 3809篇 |
内科学 | 1978篇 |
皮肤病学 | 288篇 |
神经病学 | 573篇 |
特种医学 | 2557篇 |
外国民族医学 | 1篇 |
外科学 | 1923篇 |
综合类 | 1940篇 |
一般理论 | 4篇 |
预防医学 | 4166篇 |
眼科学 | 179篇 |
药学 | 3838篇 |
43篇 | |
中国医学 | 698篇 |
肿瘤学 | 3649篇 |
出版年
2024年 | 56篇 |
2023年 | 599篇 |
2022年 | 740篇 |
2021年 | 1363篇 |
2020年 | 1382篇 |
2019年 | 1518篇 |
2018年 | 1489篇 |
2017年 | 1274篇 |
2016年 | 1201篇 |
2015年 | 1149篇 |
2014年 | 1946篇 |
2013年 | 2289篇 |
2012年 | 1708篇 |
2011年 | 1505篇 |
2010年 | 1209篇 |
2009年 | 1193篇 |
2008年 | 1052篇 |
2007年 | 964篇 |
2006年 | 879篇 |
2005年 | 645篇 |
2004年 | 462篇 |
2003年 | 363篇 |
2002年 | 340篇 |
2001年 | 283篇 |
2000年 | 207篇 |
1999年 | 187篇 |
1998年 | 210篇 |
1997年 | 140篇 |
1996年 | 141篇 |
1995年 | 143篇 |
1994年 | 68篇 |
1993年 | 50篇 |
1992年 | 62篇 |
1991年 | 47篇 |
1990年 | 48篇 |
1989年 | 45篇 |
1988年 | 39篇 |
1987年 | 36篇 |
1986年 | 44篇 |
1985年 | 116篇 |
1984年 | 104篇 |
1983年 | 92篇 |
1982年 | 67篇 |
1981年 | 79篇 |
1980年 | 74篇 |
1979年 | 75篇 |
1978年 | 16篇 |
1977年 | 10篇 |
1976年 | 9篇 |
1972年 | 6篇 |
排序方式: 共有10000条查询结果,搜索用时 718 毫秒
91.
本试验是在多种食品的基础上,加大照射剂量(吸收剂量为0.1~8.0 kGy)和提高辐照食品在膳食中比例(千重80%以上)的条件下,进行了150d的大白鼠喂养试验。通过对饲料的营养成分分析及其利用,对动物的生长发育、血液学、致突变性及病理学等项指标的检测,结果证明是安全的。本试验结果为今后辐照食品商业化提供了安全的证据。 相似文献
92.
目的 研究海生多糖肽对小鼠亚急性辐射损伤的防护作用。方法 给小鼠饲以海生多糖肽制剂,用^60Coγ射线进行全身性亚急性照射,检测外周血白细胞、脾淋巴细胞转化率、红细胞超氧化物歧化酶、丙二醛和过氧化酶含量、精子畸形率、睾丸精母细胞染色体畸变率和肝细胞半胱氨酸蛋白酶-3等指标。结果 海生多糖肽高、低剂量组小鼠的血白细胞数量、脾淋巴细胞转化率、红细胞超氧化物歧化酶值和过氧化酶值均高于照射对照组,红细胞丙二醛值、精子畸形率、睾丸精母细胞染色体畸变率和肝细胞半胱氨酸蛋白酶-3阳性表达率则低于照射对照组,差异有显著性。结论 海生多糖肽对亚急性辐射损伤有良好的防护作用。 相似文献
93.
亮菌多糖抗小鼠辐射损伤作用的研究 总被引:2,自引:0,他引:2
目的观察亮菌多糖(ATS)对辐射损伤的保护作用。方法将小鼠随机分为空白对照组(0.9%生理盐水)、辐射模型组、阳性对照组(参芪片)和ATS多糖不同剂量实验组(80、160和320mg/kg)。以γ射线照射小鼠全身,引起辐射损伤后观察各组小鼠30d存活率、白细胞(WBC)数、精子畸变率、骨髓微核(MN)细胞数、骨髓DNA含量和免疫器官重量及血清和肝组织中的超氧化物歧化酶(SOD)和丙二醛(MDA)含量等。结果ATS能提高受照小鼠存活率(P〈0.05)及SOD活性(P〈0.05)、升高WBC数(P〈0.05)和骨髓DNA含量(P〈0.05),抑制小鼠精子畸变率(P〈0.05)和骨髓MN细胞数的增加(P〈0.05),并使受照小鼠胸腺、脾脏重量回升(P〈0.05),还能增加内源性脾结节数(P〈0.05),降低MDA含量。结论ATS对γ射线所致小鼠辐射损伤有较好的保护作用。 相似文献
94.
Carole Roan Gresenz Jeannette Rogowski José J. Escarce 《Health services research》2007,42(1P1):239-264
Objective. To quantify the relationship between utilization of care among the uninsured and the structure of the local health care market and safety net.
Data Sources/Study Setting. Nationally representative data from the 1996 to 2000 waves of the Medical Expenditure Panel Survey (MEPS) linked to data from multiple secondary sources.
Study Design. We separately analyze outpatient care utilization and whether an individual incurred any medical expenditure among uninsured adults living in urban and rural areas. Safety net measures include distances between each individual and the nearest safety net providers as well as a measure of capacity based on local government and hospital health expenditures. Other covariates include the managed care presence in the local health care market, the percentage of individuals who are uninsured in the area, and local primary care physician supply. We simulate utilization using standardized predictions.
Principal Findings. Distances between the rural uninsured and safety net providers are significantly associated with utilization. In urban areas, we find that the percentage of individuals in the area who are uninsured, the pervasiveness and competitiveness of managed care, the primary care physician supply, and safety net capacity have a significant relationship with health care utilization.
Conclusions. Facilitating transport to safety net providers and increasing the number of such providers are likely to increase utilization of care among the rural uninsured. Our findings for urban areas suggest that the uninsured living in areas where managed care presence is substantial, and especially where managed care competition is limited, could be a target for policies to improve the ability of the uninsured to obtain care. Policies oriented toward enhancing funding for the safety net and increasing the capacity of safety net providers are likely to be important to ensuring the urban uninsured are able to obtain health care. 相似文献
Data Sources/Study Setting. Nationally representative data from the 1996 to 2000 waves of the Medical Expenditure Panel Survey (MEPS) linked to data from multiple secondary sources.
Study Design. We separately analyze outpatient care utilization and whether an individual incurred any medical expenditure among uninsured adults living in urban and rural areas. Safety net measures include distances between each individual and the nearest safety net providers as well as a measure of capacity based on local government and hospital health expenditures. Other covariates include the managed care presence in the local health care market, the percentage of individuals who are uninsured in the area, and local primary care physician supply. We simulate utilization using standardized predictions.
Principal Findings. Distances between the rural uninsured and safety net providers are significantly associated with utilization. In urban areas, we find that the percentage of individuals in the area who are uninsured, the pervasiveness and competitiveness of managed care, the primary care physician supply, and safety net capacity have a significant relationship with health care utilization.
Conclusions. Facilitating transport to safety net providers and increasing the number of such providers are likely to increase utilization of care among the rural uninsured. Our findings for urban areas suggest that the uninsured living in areas where managed care presence is substantial, and especially where managed care competition is limited, could be a target for policies to improve the ability of the uninsured to obtain care. Policies oriented toward enhancing funding for the safety net and increasing the capacity of safety net providers are likely to be important to ensuring the urban uninsured are able to obtain health care. 相似文献
95.
F. Estelle R. Simons on Behalf of the Early Prevention of Asthma in Atopic Children Study Group 《Pediatric allergy and immunology》2007,18(6):535-542
There are more than 40 H(1)-antihistamines available worldwide. Most of these medications have never been optimally studied in prospective, randomized, double-masked, placebo-controlled trials in children. The aim was to perform a long-term study of levocetirizine safety in young atopic children. In the randomized, double-masked Early Prevention of Asthma in Atopic Children Study, 510 atopic children who were age 12-24 months at entry received either levocetirizine 0.125 mg/kg or placebo twice daily for 18 months. Safety was assessed by: reporting of adverse events, numbers of children discontinuing the study because of adverse events, height and body mass measurements, assessment of developmental milestones, and hematology and biochemistry tests. The population evaluated for safety consisted of 255 children given levocetirizine and 255 children given placebo. The treatment groups were similar demographically, and with regard to number of children with: one or more adverse events (levocetirizine, 96.9%; placebo, 95.7%); serious adverse events (levocetirizine, 12.2%; placebo, 14.5%); medication-attributed adverse events (levocetirizine, 5.1%; placebo, 6.3%); and adverse events that led to permanent discontinuation of study medication (levocetirizine, 2.0%; placebo, 1.2%). The most frequent adverse events related to: upper respiratory tract infections, transient gastroenteritis symptoms, or exacerbations of allergic diseases. There were no significant differences between the treatment groups in height, mass, attainment of developmental milestones, and hematology and biochemistry tests. The long-term safety of levocetirizine has been confirmed in young atopic children. 相似文献
96.
他达拉非治疗勃起功能障碍的安全性研究进展 总被引:2,自引:2,他引:0
勃起功能障碍(erectile dysfunction,ED)是中老年人的常见疾病。他达拉非自2002年10月开始用于治疗ED,其疗效确切,安全性高,因此越来越多的患者选择他达拉非来治疗ED。目前对他达拉非的作用机制、药代动力学、疗效、安全性等方面已经有了较多的基础及临床研究资料。本文就他达拉非治疗ED的安全性做一综述,以求该药物在临床上得到更安全的使用,为临床医生选择使用该类药物提供参考。 相似文献
97.
Peter I. Buerhaus 《Journal of nursing scholarship》2004,36(4):366-370
PURPOSE: To describe and discuss the status of patient safety in U.S. hospitals. METHODS: Personal interview. This report is part of a series of discussions with a leading expert on patient safety. FINDINGS AND CONCLUSIONS: Some improvements have been made in the past 10 years. But changes have not been adequate. Continuing barriers include the punitive environment in hospitals, physicians' denial of the scope of the problem, lack of national leadership, and lack of systems thinking. 相似文献
98.
目的:探讨儿童在X线体检中减少照射剂量的方法。方法:应用东芝500mA遥控X线机、FJ-427型热释光剂量仪等设备,对100名3~5岁儿童体检时,随机分成两个对照组、每组50名,分别接受胸透或平片检查,对检查测得数据均进行统计学处理。结果:胸透时胸部接受的照射剂量是平片的22倍多,其它部位接受的X线散射剂量平均值之比亦在20~30倍之间。结论:在儿童X线体检中应采用常规胸片替代胸透,可以有效地降低其辐射危害。 相似文献
99.
本文回顾了伐地那非治疗勃起功能障碍(erectile dysfunction,ED)的安全性和耐受性,包括其总体安全性、心血管安全性和视觉安全性。临床试验和实际应用的实践经验证明,最常见的不良事件为头痛、颜面潮红和鼻充血,并且多为轻、中度和一过性。无论在一般ED人群中还是在难治性ED人群中,无论是短期还是长期应用,伐地那非均有良好的安全性和耐受性。 相似文献
100.
目的 探讨超氧化物歧化酶 (SOD)对急性放射性口腔炎的临床价值。方法 90例首程放疗鼻咽癌病人随机分为 3组 :A组用自制的SOD药膜 ;B组用维斯克药液 ;C组不行任何治疗。所有病人均于第 2周末开始观察、用药 ,直至放疗第 6周末。结果 A组放射性口腔炎的发病率明显低于C组 (P <0 0 5 ) ;A组放射性口腔炎的有效率明显高于C组 (P <0 0 1)。结论 SOD对急性放射性口腔炎有明显预防及治疗作用。 相似文献